MBNL2 dysfunction in outer radial glial cells is associated with disrupted corticogenesis in congenital myotonic dystrophy
Neurobiology of Disease · 2026
DOI: 10.1016/j.nbd.2026.107305 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurobiology of Disease, 2026. Verfasst von Thiéry De Serres-Bérard und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Faculty of Medicine, Université Laval, Quebec City, QC, Canada; CERVO Brain Research Centre, Quebec City, QC, Canada; Regener…. Hauptthemen laut MEDLINE: Myotonic Dystrophy, RNA-Binding Proteins, Ependymoglial Cells, Cerebral Cortex. Die Arbeit nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: AFM-Téléthon, Muscular Dystrophy Canada, Université Laval.
Abstract (Originalsprache)
Myotonic dystrophy type 1 (DM1) arises from toxic CUG-expanded DMPK transcripts that sequester Muscleblind-like (MBNL) proteins, yet how this molecular lesion perturbs brain development in congenital DM1 (CDM) remains unknown. Here, we identify an unanticipated developmental role for MBNL2 in outer radial glial cells, a progenitor population critical for cortical expansion. We demonstrate that MBNL2 is expressed in these cells both in vivo and in forebrain organoids derived from patient-specific human induced pluripotent stem cells (hiPSCs), rendering them particularly sensitive to MBNL2 titration. Using genome editing to excise the CTG repeats in the DMPK gene, we provide evidence that the expanded trinucleotide tract directly contributes to defective neuronal migration and impaired differentiation of late-born cortical neurons in CDM organoids. These findings redefine MBNL2 as a potential regulator of human corticogenesis and uncover a developmental mechanism by which RNA toxicity drives this severe form of DM1. By revealing a prenatal origin for CDM neuropathology linked to MBNL2 dysfunction, this work opens avenues for therapeutic strategies targeting early developmental windows.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Faculty of Medicine, Université Laval, Quebec City, QC, Canada; CERVO Brain Research Centre, Quebec City, QC, Canada; Regenerative Medicine Division, CHU de Québec-Université Laval Research cente…
- Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA; Sanford Stem Cell Institute and UCSD Stem Cell Program, University of California San Diego, La Jolla, CA, USA; Instit…
- Department of Medicine, Faculty of Medicine, Université Laval, Quebec City, QC, Canada; Regenerative Medicine Division, CHU de Québec-Université Laval Research center, Quebec City, QC, Canada; LOEX, CHU de Québec-Univer…
- Department of Medicine, Faculty of Medicine, Université Laval, Quebec City, QC, Canada; CERVO Brain Research Centre, Quebec City, QC, Canada. Electronic address: Mohamed.Chahine@phc.ulaval.ca.
Förderung
- AFM-Téléthon
- Muscular Dystrophy Canada
- Université Laval
- Fonds de recherche du Québec
- US Department of Defense
- Association Française contre les Myopathies
- Myotonic Dystrophy Foundation
- Canadian Institutes of Health Research
Zitieren
APA
De Serres-Bérard, T., Gosztyla, M. L., Nguyen, G., Yeo, G. W., Puymirat, J., & Chahine, M. (2026). MBNL2 dysfunction in outer radial glial cells is associated with disrupted corticogenesis in congenital myotonic dystrophy. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2026.107305
Vancouver
De Serres-Bérard T, Gosztyla ML, Nguyen G, Yeo GW, Puymirat J, Chahine M. MBNL2 dysfunction in outer radial glial cells is associated with disrupted corticogenesis in congenital myotonic dystrophy. Neurobiology of Disease. 2026. doi:10.1016/j.nbd.2026.107305
BibTeX
@article{DeSerresBrard2026,
author = {De Serres-Bérard, Thiéry and Gosztyla, Maya L and Nguyen, Grady and Yeo, Gene W and Puymirat, Jack and Chahine, Mohamed},
title = {MBNL2 dysfunction in outer radial glial cells is associated with disrupted corticogenesis in congenital myotonic dystrophy},
journal = {Neurobiology of Disease},
year = {2026},
doi = {10.1016/j.nbd.2026.107305}
}
EUVIMED